A 13D filing on Thursday disclosed a letter of intent that a portfolio company of a BlackRock (NYSE: BLK) fund intends to make a proposal to transact with certain non-core assets of Tabula Rasa Healthcare (Nasdaq: TRHC).
Why it matters: Axios reported in late March that Tabula Rasa, working with Citigroup, was in advanced discussions regarding the sale of non-core assets, including PrescribeWellness.
